相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A unique peptide-based pharmacophore identifies an inhibitory compound against the A-subunit of Shiga toxin
Miho Watanabe-Takahashi et al.
SCIENTIFIC REPORTS (2022)
Identification of a peptide motif that potently inhibits two functionally distinct subunits of Shiga toxin
Miho Watanabe-Takahashi et al.
COMMUNICATIONS BIOLOGY (2021)
The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection
Jumpei Omi et al.
NATURE COMMUNICATIONS (2020)
Host response to the subtilase cytotoxin produced by locus of enterocyte effacement-negative Shiga-toxigenicEscherichia coli
Hiroyasu Tsutsuki et al.
MICROBIOLOGY AND IMMUNOLOGY (2020)
A CRISPR Screen Using Subtilase Cytotoxin Identifies SLC39A9 as a Glycan-Regulating Factor
Toshiyuki Yamaji et al.
ISCIENCE (2019)
Affinity-Based Screening of Tetravalent Peptides Identifies SubtypeS-elective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition
Takaaki Mitsui et al.
INFECTION AND IMMUNITY (2016)
Identification of a Wide Range of Motifs Inhibitory to Shiga Toxin by Affinity-Driven Screening of Customized Divalent Peptides Synthesized on a Membrane
Mihoko Kato et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Identification of a Peptide-Based Neutralizer That Potently Inhibits Both Shiga Toxins 1 and 2 by Targeting Specific Receptor-Binding Regions
Kazue Tsutsuki et al.
INFECTION AND IMMUNITY (2013)
Recent Progress of Shiga Toxin Neutralizer for Treatment of Infections by Shiga Toxin-Producing Escherichia coli
Kiyotaka Nishikawa
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Distinct Physiologic and Inflammatory Responses Elicited in Baboons after Challenge with Shiga Toxin Type 1 or 2 from Enterohemorrhagic Escherichia coli
D. J. Stearns-Kurosawa et al.
INFECTION AND IMMUNITY (2010)
Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways
Jennifer J. Wolfson et al.
CELLULAR MICROBIOLOGY (2008)
Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin
Emma Byres et al.
NATURE (2008)
Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum
Hui Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin
Kiyotaka Nishikawa et al.
FASEB JOURNAL (2006)
AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP
Adrienne W. Paton et al.
NATURE (2006)
Identification and characterization of receptors for vacuolating activity of subtilase cytotoxin
Kinnosuke Yahiro et al.
MOLECULAR MICROBIOLOGY (2006)
Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues
M Watanabe et al.
INFECTION AND IMMUNITY (2006)
Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation
K Nishikawa et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections
M Watanabe et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli
AW Paton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7
ME Fraser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7
K Nishikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
